Clinical trial
A Multicenter, Prospective, Randomized, Single-blind, Pivotal Clinical Study to Evaluate the Safety and Efficacy of GENOSS® DCB Versus SeQuent® Please NEO in Patients With Coronary De Novo Lesions
NCT05096442 is registered in ClinicalTrials.gov with Genoss Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Prospective, Randomized, Single-blind, Pivotal Clinical Study to Evaluate the Safety and Efficacy of GENOSS® DCB Versus SeQuent® Please NEO in Patients With Coronary De Novo Lesions
- Lead sponsor
- Genoss Co., Ltd.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 30, 2021
- Completion date
- November 21, 2023
- Enrollment
- 204 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.